Global Cord Blood Corporation (CO) Just Recorded A Sigfniciant Decline

The stock of Global Cord Blood Corporation (NYSE:CO) is a huge mover today! The stock decreased 4.78% or $0.22 during the last trading session, reaching $4.38. About 145,128 shares traded or 67.04% up from the average. Global Cord Blood Corporation (NYSE:CO) has declined 26.46% since September 13, 2018 and is downtrending. It has underperformed by 26.46% the S&P500.
The move comes after 7 months negative chart setup for the $532.39 million company. It was reported on Sep, 13 by We have $4.16 PT which if reached, will make NYSE:CO worth $26.62 million less.

More notable recent Global Cord Blood Corporation (NYSE:CO) news were published by: which released: “When Should You Buy Southwest Airlines Co. (NYSE:LUV)? – Yahoo Finance” on August 30, 2019, also with their article: “Should You Be Concerned About Cimarex Energy Co.’s (NYSE:XEC) Historical Volatility? – Yahoo Finance” published on August 30, 2019, published: “Cloudflare (NYSE:NET) IPO Debuts on NYSE, Price Soars 27%, Co-Founders’ Comments – LearnBonds” on September 13, 2019. More interesting news about Global Cord Blood Corporation (NYSE:CO) were released by: and their article: “Why JPMorgan Chase & Co. (NYSE:JPM) Is A Dividend Rockstar – Yahoo Finance” published on August 31, 2019 as well as‘s news article titled: “Stocks That Hit 52-Week Lows On Tuesday – Benzinga” with publication date: August 27, 2019.

China Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company has market cap of $532.39 million. The firm offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. It has a 14.95 P/E ratio. As of March 31, 2017, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.